NCT02154022View on ClinicalTrials.gov

Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 1, 2029

Study Completion Date

May 1, 2030

Conditions
CancerSolid TumorsNeoplasm
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH